Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation

An Early Regional Experience with Expansion of Milan Criteria for Liver Transplant Recipients

(2010) J. J. Guiteau et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion

(2010) Derek DuBay et al.   ANNALS OF SURGERY

Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor

(2009) E. Vibert et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation

(2009) Oliver B. Lao et al.   CLINICAL TRANSPLANTATION

Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation

(2009) Srinath Chinnakotla et al.   LIVER TRANSPLANTATION

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States

(2009) Elizabeth A. Pomfret et al.   LIVER TRANSPLANTATION

Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria

(2008) M. Ravaioli et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A Novel Model Measuring the Harm of Transplanting Hepatocellular Carcinoma Exceeding Milan Criteria

(2008) M. L. Volk et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis

(2008) Francis Y. Yao et al.   HEPATOLOGY